SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
SmartTRAK reviews possible alternatives to LCDs and CMS’ proposed payment model for Cellular, Acellular,...
Patient demand, enabling technologies and the ASC shift create a perfect storm for the direct anterior a...
Cerapedics’ CEO Valeska Schroeder discusses the company’s newly PMA-approved PearlMatrix P-15 Peptide En...
James Voos, MD, chair of the Department of Orthopedics and Sports Medicine at University Hospitals Cleve...
SmartTRAK's industry experts discuss CMS’ proposed changes to skin substitutes reimbursement and their p...
Nicolas Piuzzi, MD, discusses the upcoming 2025 Robotic Orthopedic Concepts and Knowledge Symposium (ROC...
Stewart Strong, Q’Apel Medical’s recently appointed CEO, discusses the company, his priorities and plans...
SmartTRAK reviews CMS’ new WISeR model and its potential impact on the US Skin Substitutes Market. A new...
NASS Executive Director and CEO Eric Muehlbauer discusses NASS’s new Innovation NetWORK Summit in an int...
SmartTRAK is excited to attend the Society of Neurointerventional Surgery’s (SNIS) 22nd Annual Meeting &...
Login